Publications by authors named "Maria Rettenbacher"

Claim this Profile
T
The relationship between childhood maltreatment and trauma and psychosis is not moderated by parental mental health.
Nina Mørkved, Pia Sophie Bryntesen, Ida Marie Eggen, Erik Johnsen, Rune Andreas Kroken, Maria Rettenbacher

BMC Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine.
Petros Drosos, Erik Johnsen, Christoffer Andreas Bartz-Johannessen, Tor Ketil Larsen, Solveig Klæbo Reitan, Maria Rettenbacher

Schizophr Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular adhesion molecules in drug-naïve and previously medicated patients with schizophrenia-spectrum disorders.
Kristian Varden Gjerde, Christoffer Bartz-Johannessen, Vidar Martin Steen, Ole A Andreassen, Nils Eiel Steen, Maria Rettenbacher

Schizophr Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to a Letter to the Editors From Dr de Souza and colleagues: "Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum: A Quest for Clarity".
Eirik Kjelby, Rolf Gjestad, Farivar Fathian, Igne Sinkeviciute, Renata Alisauskiene, Maria Rettenbacher

J Clin Psychopharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study.
Renata Alisauskiene, Erik Johnsen, Rolf Gjestad, Rune A Kroken, Eirik Kjelby, Maria Rettenbacher

Gen Hosp Psychiatry· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro).
Eirik Kjelby, Rolf Gjestad, Farivar Fathian, Igne Sinkeviciute, Renata Alisauskiene, Maria Rettenbacher

J Clin Psychopharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression trajectories and cytokines in schizophrenia spectrum disorders - A longitudinal observational study.
Gunnhild E Hoprekstad, Eirik Kjelby, Rolf Gjestad, Farivar Fathian, Tor K Larsen, Maria Rettenbacher

Schizophr Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis.
Farivar Fathian, Rolf Gjestad, Rune A Kroken, Else-Marie Løberg, Solveig Klæbo Reitan, Maria Rettenbacher

Schizophr Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness.
Petros Drosos, Erik Johnsen, Christoffer Andreas Bartz-Johannessen, Tor Ketil Larsen, Solveig Klæbo Reitan, Maria Rettenbacher

World J Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Effectiveness of Atypical Antipsychotics on Hallucinations: A Pragmatic Randomized Controlled Trial.
Igne Sinkeviciute, Kenneth Hugdahl, Christoffer Bartz-Johannessen, Rune Andreas Kroken, Else-Marie Løberg, Maria Anna Rettenbacher

J Clin Psychopharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT.
Liss Anda, Erik Johnsen, Rune A Kroken, Inge Joa, Maria Rettenbacher

Schizophr Res Cogn· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study.
Jeanette Brun Larsen, Solveig Klæbo Reitan, Else-Marie Løberg, Maria Rettenbacher, Øystein Bruserud

Brain Behav Immun Health· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study.
Sanne Hoekstra, Christoffer Bartz-Johannessen, Igne Sinkeviciute, Solveig K Reitan, Rune A Kroken, Maria Rettenbacher

NPJ Schizophr· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
Erik Johnsen, Rune A Kroken, Else-Marie Løberg, Maria Rettenbacher, Inge Joa

Lancet Psychiatry· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: manic episode with psychotic symptoms induced by hyponatremia.
Laurin Mauracher, Maria Rettenbacher

Neuropsychiatr· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Changes in psychopathology in schizophrenia patients starting treatment with new-generation antipsychotics: therapeutic drug monitoring in a naturalistic treatment setting" [Eur. Neuropsychopharmacol. 26 (2016) 717-728].
Alexandra Kaufmann, Fabienne Post, Nursen Yalcin-Siedentopf, Susanne Baumgartner, Falko Biedermann, Maria A Rettenbacher

Eur Neuropsychopharmacol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms.
Liss Anda, Kolbjørn K Brønnick, Jan Olav Johannessen, Inge Joa, Rune A Kroken, Maria Rettenbacher

Front Psychiatry· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
Christian G Widschwendter, Georg Kemmler, Maria A Rettenbacher, Nursen Yalcin-Siedentopf, Alex Hofer

BMC Psychiatry· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood trauma in schizophrenia spectrum disorders as compared to substance abuse disorders.
Nina Mørkved, Dagfinn Winje, Anders Dovran, Kjersti Arefjord, Erik Johnsen, Maria Rettenbacher

Psychiatry Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why do indiviuals with schizophrenia drop out of observational clinical trials?
Alex Hofer, Verena Radner, Monika Edlinger, Georg Kemmler, Maria A Rettenbacher

Psychiatry Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing Practice in Inpatients Versus Outpatients With Schizophrenia Initiating Treatment With Second-Generation Antipsychotics: A Naturalistic Follow-Up Study.
Monika Edlinger, Maria A Rettenbacher, Georg Kemmler, Falko Biedermann, Christian G Widschwendter

J Clin Psychopharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Alliance in Patients With Schizophrenia: Introduction of a New Rating Instrument.
Christian G Widschwendter, Alex Hofer, Susanne Baumgartner, Monika Edlinger, Georg Kemmler, Maria A Rettenbacher

J Psychiatr Pract· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in psychopathology in schizophrenia patients starting treatment with new-generation antipsychotics: therapeutic drug monitoring in a naturalistic treatment setting.
Alexandra Kaufmann, Fabienne Wartelsteiner, Nursen Yalcin-Siedentopf, Susanne Baumgartner, Falko Biedermann, Maria A Rettenbacher

Eur Neuropsychopharmacol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilirubin concentration correlates with positive symptoms in patients with schizophrenia.
Christian G Widschwendter, Maria A Rettenbacher, Georg Kemmler, Monika Edlinger, Susanne Baumgartner

J Clin Psychiatry· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis